At the University of Iowa we have assembled a remarkably strong team of oncologists, clinical imaging specialists, computer scientists, imaging and therapy physicists, bioinformatics specialists, and statisticians, as well as collaboration with NIST and a public/private partnership with Siemens. This group is an ideal team to address the goals of this UOI Program Announcement and contribute robustly to the envisioned Quantitative Imaging Network (QIN). We plan to achieve our goals through:
Specific Aim 1 : Create an accessible environment for quantitative image analysis tool development and testing using an existing large H&N cancer dataset and caBIG. 1a: We plan to design and deploy a broadly connected informatics system architecture to support a locally networked relational database for development, implementation and validation of shared tools to the QIN through caBIG and the National Cancer Imaging Archive (NCIA). 1b: We will Interface our large PET/CT imaging and clinical outcomes database of pre and post therapy H&N cancer patients as a universally accessible test database that will be shared with the QIN.
Specific Aim 2 : Develop novel semi-automated tools for quantitative image-based response assessment. 2a: We will design, implement, and validate open source 2D and 3D semi- automated quantitative image analysis tools for tumor definition and quantitative metrics applicable to response assessment. We will also develop and apply advanced decision-support software as well as measurement variability tools so that image analysis tools can be compared and optimally selected for clinical cancer trials. 2b. We will test these image analysis tools on the imaging and clinical data to assess applicability and accessibility by QIN.
Specific Aim 3 : Establish robust quality procedures and standards for quantitative imaging, working with NIST and the QIN to enhance the quality and reliability of quantitative imaging for clinical decision-making. 3a: Define and validate calibration procedures, tools and standards for PET imaging using a Ge-68 NIST-traceable phantom. 3b: Define and validate robust quality assurance tools and standards for 4D PET/CT 3c: Define similar tools and standards for quantitative imaging response assessment using ACR and GE phantoms for MRI, including MRSI.
Specific Aim 4 : Adapt and Enhance Quantitative Image-based Response Assessment for Clinical Trials Decision-Support. 3a: In an existing, NCI-funded study of FDG and F-18 fiuorothymidine in head and neck cancer patients. 3b In an existing, NCI-funded study of FDG and C-11 acetate imaging in lung cancer and 3c: In a planned clinical trial of MRSI and F-18 fluorodopa in high-grade gliomas.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
1U01CA140206-01A1
Application #
7891013
Study Section
Special Emphasis Panel (ZCA1-SRLB-9 (J1))
Program Officer
Nordstrom, Robert J
Project Start
2010-04-01
Project End
2015-03-31
Budget Start
2010-04-01
Budget End
2011-03-31
Support Year
1
Fiscal Year
2010
Total Cost
$607,188
Indirect Cost
Name
University of Iowa
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Byrd, Darrin; Christopfel, Rebecca; Buatti, John et al. (2018) Multicenter survey of PET/CT protocol parameters that affect standardized uptake values. J Med Imaging (Bellingham) 5:011012
Ulrich, Ethan J; Sunderland, John J; Smith, Brian J et al. (2018) Automated model-based quantitative analysis of phantoms with spherical inserts in FDG PET scans. Med Phys 45:258-276
Beichel, Reinhard R; Smith, Brian J; Bauer, Christian et al. (2017) Multi-site quality and variability analysis of 3D FDG PET segmentations based on phantom and clinical image data. Med Phys 44:479-496
Schoenfeld, Joshua D; Sibenaller, Zita A; Mapuskar, Kranti A et al. (2017) O2?- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate. Cancer Cell 31:487-500.e8
Smith, Brian J; Beichel, Reinhard R (2017) A Bayesian framework for performance assessment and comparison of imaging biomarker quantification methods. Stat Methods Med Res :962280217741334
McGuire, Sarah M; Bhatia, Sudershan K; Sun, Wenqing et al. (2016) Using [(18)F]Fluorothymidine Imaged With Positron Emission Tomography to Quantify and Reduce Hematologic Toxicity Due to Chemoradiation Therapy for Pelvic Cancer Patients. Int J Radiat Oncol Biol Phys 96:228-39
Pierce II, Larry A; Byrd, Darrin W; Elston, Brian F et al. (2016) An algorithm for automated ROI definition in water or epoxy-filled NEMA NU-2 image quality phantoms. J Appl Clin Med Phys 17:440–456
Farahani, Keyvan; Kalpathy-Cramer, Jayashree; Chenevert, Thomas L et al. (2016) Computational Challenges and Collaborative Projects in the NCI Quantitative Imaging Network. Tomography 2:242-249
Yankeelov, Thomas E; Mankoff, David A; Schwartz, Lawrence H et al. (2016) Quantitative Imaging in Cancer Clinical Trials. Clin Cancer Res 22:284-90
Fedorov, Andriy; Clunie, David; Ulrich, Ethan et al. (2016) DICOM for quantitative imaging biomarker development: a standards based approach to sharing clinical data and structured PET/CT analysis results in head and neck cancer research. PeerJ 4:e2057

Showing the most recent 10 out of 28 publications